Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Total Current Liabilities: 2020-2023

Historic Total Current Liabilities for Therapeutics (RAPT) over the last 4 years, with Dec 2023 value amounting to $21.8 million.

  • Therapeutics' Total Current Liabilities fell 52.57% to $10.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $10.4 million, marking a year-over-year decrease of 52.57%. This contributed to the annual value of $21.8 million for FY2023, which is 53.52% up from last year.
  • Latest data reveals that Therapeutics reported Total Current Liabilities of $21.8 million as of FY2023, which was up 53.52% from $14.2 million recorded in FY2022.
  • Over the past 5 years, Therapeutics' Total Current Liabilities peaked at $21.8 million during FY2023, and registered a low of $9.6 million during FY2021.
  • Over the past 3 years, Therapeutics' median Total Current Liabilities value was $14.2 million (recorded in 2022), while the average stood at $15.2 million.
  • As far as peak fluctuations go, Therapeutics' Total Current Liabilities decreased by 18.28% in 2021, and later skyrocketed by 53.52% in 2023.
  • Over the past 4 years, Therapeutics' Total Current Liabilities (Yearly) stood at $11.7 million in 2020, then decreased by 18.28% to $9.6 million in 2021, then skyrocketed by 48.24% to $14.2 million in 2022, then skyrocketed by 53.52% to $21.8 million in 2023.